Oncovin and blood fibrinogen decreased Patient Reports February 12, 2012

Oncovin Side Effects Report #4620255-8
Oncovin side effect was reported by a Physician from on Mar 09, 2005. Female patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase decreased, blood fibrinogen decreased, gamma-glutamyltransferase increased, hepatic function abnormal. Oncovin dosage: 1.3 MG/M2 OTHER. During the same period patient was treated with DAUNORUBICIN, CYCLOPHOSPHAMIDE, ELSPAR, PREDNISOLONE. Patient recovered.

Oncovin Side Effects Report #4649843-X
Oncovin side effect was reported by a Physician from on Apr 08, 2005. Female patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase decreased, blood fibrinogen decreased, condition aggravated. Oncovin dosage: 1.3 MG/M2 OTHER. During the same period patient was treated with DAUNORUBICIN, CYCLOPHOSPHAMIDE, LEUNASE, PREDNISOLONE. Patient recovered.

Oncovin Side Effects Report #5198054-0
Oncovin side effect was reported by a Consumer or non-health professional from JAPAN on Dec 22, 2006. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, hyponatraemia. Oncovin dosage: unknown. During the same period patient was treated with GLEEVEC. Patient recovered.

Oncovin Side Effects Report #5225278-6
Oncovin side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. Oncovin dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.


Oncovin Side Effects Report #5417778-0
Oncovin side effect was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. Oncovin dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.